🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/10/2002 | 42,33 | 44,04 | 41,94 | 42,11 | -0,29% | 4,96% | 6.666.538 |
| 04/10/2002 | 43,71 | 43,89 | 41,77 | 42,23 | -4,39% | 4,87% | 8.416.698 |
| 03/10/2002 | 44,70 | 45,94 | 43,67 | 44,17 | -1,41% | 5,06% | 6.522.123 |
| 02/10/2002 | 44,80 | 45,68 | 44,42 | 44,80 | +1,23% | 2,81% | 6.852.348 |
| 01/10/2002 | 44,18 | 44,37 | 43,23 | 44,26 | +1,47% | 2,57% | 9.034.284 |
| 30/09/2002 | 44,14 | 44,32 | 43,05 | 43,62 | -1,19% | 2,88% | 7.777.942 |
| 27/09/2002 | 45,71 | 46,28 | 43,94 | 44,14 | -5,11% | 5,11% | 7.951.176 |
| 26/09/2002 | 45,52 | 46,52 | 45,31 | 46,52 | +2,20% | 2,64% | 6.995.190 |
| 25/09/2002 | 44,18 | 45,80 | 44,09 | 45,52 | +3,92% | 3,87% | 6.686.135 |
| 24/09/2002 | 42,61 | 44,11 | 42,40 | 43,80 | +1,44% | 4,01% | 6.743.356 |
| 23/09/2002 | 42,99 | 43,65 | 42,76 | 43,18 | -1,07% | 2,06% | 5.589.718 |
| 20/09/2002 | 43,11 | 43,98 | 43,11 | 43,65 | +1,22% | 2,01% | 10.351.306 |
| 19/09/2002 | 43,96 | 44,75 | 43,01 | 43,12 | -3,97% | 3,97% | 5.852.137 |
| 18/09/2002 | 44,94 | 45,60 | 44,34 | 44,90 | -0,59% | 2,80% | 6.047.694 |
| 17/09/2002 | 47,32 | 47,38 | 44,86 | 45,17 | -3,01% | 5,32% | 6.726.483 |
| 16/09/2002 | 46,57 | 46,91 | 45,66 | 46,57 | -0,93% | 2,68% | 4.263.159 |
| 13/09/2002 | 46,66 | 47,28 | 45,80 | 47,01 | +0,35% | 3,17% | 4.223.335 |
| 12/09/2002 | 46,66 | 47,42 | 46,52 | 46,85 | -0,95% | 1,94% | 5.841.866 |
| 11/09/2002 | 47,85 | 48,02 | 47,19 | 47,30 | -0,14% | 1,73% | 2.908.934 |
| 10/09/2002 | 47,15 | 47,63 | 46,76 | 47,37 | +0,49% | 1,86% | 2.995.498 |
| 09/09/2002 | 46,37 | 47,68 | 46,18 | 47,14 | +1,65% | 3,23% | 5.137.506 |
| 06/09/2002 | 46,73 | 46,73 | 45,82 | 46,37 | +0,62% | 1,94% | 4.557.018 |
| 05/09/2002 | 45,80 | 46,74 | 45,09 | 46,09 | -1,69% | 3,60% | 6.679.428 |
| 04/09/2002 | 45,32 | 47,00 | 45,04 | 46,88 | +2,63% | 4,34% | 7.109.318 |
| 03/09/2002 | 47,19 | 47,47 | 45,56 | 45,68 | -5,25% | 4,04% | 6.717.261 |
| 30/08/2002 | 48,33 | 49,10 | 47,95 | 48,21 | -0,43% | 2,39% | 4.541.613 |
| 29/08/2002 | 47,48 | 49,14 | 47,48 | 48,42 | +0,20% | 3,50% | 4.260.015 |
| 28/08/2002 | 48,66 | 49,24 | 47,97 | 48,32 | -1,97% | 2,61% | 4.809.586 |
| 27/08/2002 | 50,08 | 50,58 | 49,07 | 49,29 | -1,92% | 3,01% | 4.505.142 |
| 26/08/2002 | 50,15 | 50,57 | 49,23 | 50,26 | +0,21% | 2,68% | 4.823.839 |